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Abstract
Experimental stroke in rodents, via middle cerebral artery occlusion (MCAO), can be associ-
ated with a negative impact on wellbeing and mortality. In hypertensive rodents, pre-stroke
craniotomy increased survival and decreased body weight loss post-MCAO. Here we deter-
mined the effect, in normotensive Sprague-Dawley rats following 60 minutes MCAO, with or
without pre-surgical craniotomy, on post-stroke outcomes in terms of weight loss, neurologi-
cal deficit, lesion volume and functional outcomes. There was no effect of pre-stroke craniot-
omy on indicators of wellbeing including survival rate (P = 0.32), body weight loss (P = 0.42)
and neurological deficit (P = 0.75). We also assessed common outcome measures following
experimental stroke and found no effect of pre-stroke craniotomy on lesion volume as mea-
sured by T2-weighted MRI (P = 0.846), or functional performance up to 28 days post-MCAO
(staircase test, P = 0.32; adhesive sticker test, P = 0.49; cylinder test, P = 0.38). Thus, pre-
stroke craniotomy did not improve animal welfare in terms of body weight loss and neurolog-
ical deficit. However, it is important, given that a number of drug delivery studies utilise the
craniotomy procedure, to note that there was no effect on lesion volume or functional out-
come following experimental stroke.
Introduction
Cerebral ischemic stroke is a leading cause of death and adult disability. However, current
available treatments are limited in both their utility and effectiveness. In fact, tissue plasmino-
gen activator (tPA) is the only specific pharmacological approach with proven efficacy for
ischemic stroke [1,2]. However, due to a narrow therapeutic window (<4.5h) and not all
stroke patients being eligible for tPA treatment, approximately only 15% stroke patients
receive tPA and recanalization rates can be less than 50% [3,4]. The development of safe and
effective treatments is a substantial challenge to stroke research. Translation of therapeutic
strategies for stroke treatment is dependent on the reproducibility and reliability of animal
stroke models. Experimental models of stroke have been developed to understand the
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pathophysiological mechanisms underlying ischemic stroke and to study neuroprotective and/
or neuroreparative strategies.
Although experimental stroke models are demonstrated to have high construct validity [5],
they do have significant impact on animal wellbeing including weight loss, risk of mortality
and behavioural deficits. Mortality rates vary widely according to species, type and duration of
ischemia induced, experimenter experience and post-surgery care and a relatively recent
review reports mortality rates anywhere between 0–33% [6]. Problems with mortality are
increased as the duration of occlusion is increased and have been shown, in human stroke
patients, to occur as a consequence of brain swelling and increased intracranial pressure [7,8].
The majority of rodent ischemic stroke models target the middle cerebral artery with either
transient or permanent occlusion. In terms of a closed skull approach this largely involves
mechanical occlusion of the middle cerebral artery intra-luminally using a filament along with
clips and/or sutures to tie off the artery or applying compression to stop the flow through the
artery. As reported by Percie du Sert et al., [9] stroke patients and experimental stroke studies
are similar in that they often show a large heterogeneity in outcome measures including mor-
bidity and mortality within a group of animals exposed to a standard ischemic stroke.
A recent study [10] demonstrated, in hypertensive male rats, that a brief pre-stroke surgical
procedure (i.e. small cranial burr hole) significantly improved survival without impacting
upon the amount of damage or functional deficit produced. However, over 90% of experimen-
tal stroke studies are conducted in ‘normal’ animals–thus, it is important to investigate
whether this surgical intervention has the same benefit on survival and animal welfare for nor-
motensive rodents undergoing middle cerebral artery occlusion (MCAO). In addition, a num-
ber of studies utilise intracranial delivery of drugs (via a small cranial burr hole) and therefore
it is relevant to consider what impact that approach may have. Here we report, that in normo-
tensive male rats, pre-stroke surgical procedure did not improve animal welfare in terms of
body weight loss and neurological deficit following 60 minutes of MCAO. In addition, such a
procedure did not affect the primary outcome measure, i.e. lesion volume, used in the majority
of experimental studies or behavioural outcome.
Materials and methods
Animals
This study was conducted in accordance with the UK Animals (Scientific Procedures) Act,
1986 (Project License 60/4315) and following institutional ethical approval by the University
of Leicester Animal and Welfare Ethical Review Body. All rats were adult male Sprague Dawley
(Charles River, Oxford, UK) aged between 11 and 12 weeks at the time of MCAO surgery. Ani-
mals were housed in groups of 3 and half of the cages were randomly selected to undergo cra-
niotomy surgery prior to MCAO. A total of 18 male rats were used in the current study: 3 were
humanely killed, using an overdose of anaesthetic (pentobarbital) followed by severance of the
femoral artery, within the first 48h following MCAO, 1 animal died during MCAO and 1 died
at day 26. All experiments are reported in accordance with the Animal research reporting of in
vivo experiments (ARRIVE) guidelines [11]. On day 28 post-MACO all animals were
humanely killed using an overdose of an anaesthetic (pentobarbital) followed by severance of
the femoral artery.
Pre-stroke craniotomy
Six days prior to MCAO surgery the craniotomy group underwent craniotomy surgery. Anaes-
thesia was induced with isoflurane (induction 5%; maintenance 2% in 100% oxygen). The ani-
mal was placed into a stereotaxic frame (Kopf Instruments, Tujunga, CA, USA) and an
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incision was made down the midline of the scalp to expose the skull. The skull was cleared of
all overlying tissue and a 0.9mm burrhole was made -1.6mm lateral to bregma. A 25G needle
was used to pierce the dura and the hole was sealed with dental cement. The wound was sealed
with subcutaneous sutures and the animals allowed to recover until subsequent MCAO
surgery.
Focal cerebral ischemia
Anaesthesia was induced with isoflurane (induction 5%; maintenance 2% in N2O/O2, 30%/70%)
and body temperature was monitored with a rectal probe and maintained using a heat mat (Har-
vard Apparatus, Holliston, MA, USA). Sixty minutes of focal cerebral ischemia was induced by
occluding the right middle cerebral artery. A small incision was made on the ventral surface of the
neck and the right common carotid artery (CCA) was isolated from the surrounding tissue. A 6–0
silk suture was used to permanently ligate the CCA at the base of the incision, and a microvascular
clip (WPA, Hertfordshire, UK) was temporarily placed below the bifurcation of the CCA into the
internal carotid artery (ICA) and external carotid artery. A 4–0 nylon filament (Droccol, MA,
USA) was inserted into the CCA through a small incision and was held in place by an additional
6–0 suture tie. The vessel clamp was removed and the filament was advanced through the ICA to
the origin of the MCA. Laser Doppler flowmetry (Moor Instruments, Axminster, UK) was used
to monitor the cerebral blood flow (CBF) to the affected area for 5 minutes prior to and 5 minutes
following occlusion. Animals were allowed to recover during the occlusion period before being
reanesthetised and the filament withdrawn.
Analgesia and welfare monitoring
Those rats undergoing craniotomy surgery received subcutaneous buprenorphine (0.002mg/
kg, Vetergesic), Marcaine at the area of incision (2mg/kg, 0.25% w/v, AstraZeneca, UK), and
1ml subcutaneous saline prior to surgery. Immediately prior to MCAO, all rats received subcu-
taneous Buprenorphine (0.003mg/kg, Vetergesic) along with Marcaine (2mg/kg, 0.25% w/v,
AstraZeneca, UK) applied directly to the skin surrounding the wound site at the point of
wound suture. All rats received saline intraperitoneally (2 ml) prior to surgery and subcutane-
ously (2 ml) immediately following MCAO to prevent dehydration. All rats were administered
Carprieve (10mg/kg, 5% w/v, Norbrook Laboratories Ltd., UK) at 4 hours post-MCAO along
with sub-cutaneous saline (2 ml) and all rats received paracetamol for 48 hours following
MCAO in jelly for self-administration. 24 hours following MCAO, grimace scoring [12]
enabled the assessment of post-operative pain levels post-MCAO in order to inform the deci-
sion as to whether further analgesia was required, one animal received an additional dose of
Carprieve (10mg/kg). Rats were weighed daily from their first surgery until day 28 post-
MCAO as an indicator of their general well-being and body weight changes presented as a per-
centage change compared to pre-MCAO. For each rat, daily observation score sheets were
completed to record the presence of any clinical signs. All rats received subcutaneous (2 ml)
pre-warmed saline twice daily following MCAO for 48 hours and had unrestricted access to
wet mashed pellets, diet gel (76A Purified soft diet, ClearH2O.com), hydrogel (98% sterile
water, ClearH2O.com), dry food pellets and water. At days 1, 2, 9, 16, 23 and 28 post-MCAO
rats were assessed using a 28-point neurological deficit score which evaluates circling move-
ments, grasping ability and whisker response.
MRI and image processing
As described previously in detail [13] MRI scanning was performed on a 9.4T Agilent scanner
(Agilent Technologies, Santa Clare, CA, USA) with a 310 mm bore diameter and 12 cm inner-
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diameter gradient (600 mT/m maximum gradient strength), interfaced with a DirectDrive
Console. Diffusion tensor imaging (DTI) and T2-weighted (T2w) images were acquired at 48h
post-MCAO. Infarct volumes were delineated on T2-weighted images. Apparent diffusion
coefficient (ADC) and fractional anisotropy (FA) maps were generated from DTI data. Rats
were fixed in a rat holder with a bite bar and ear inserts (RAPID Biomedical GmBH, Rimpar,
Germany). Physiological monitoring was achieved using a custom monitoring and gating sys-
tem (SA Instruments Inc, Stony Brook, NY, USA). Body temperature was maintained at 37˚C
using a warm air fan and rectal temperature probe. Respiration was measured using a pneu-
matic pillow. All scans were performed during the light cycle under anesthesia using 1% - 2%
isoflurane in oxygen. Radio frequency transmission and reception was achieved with a 72 mm
volume coil and 2-channel surface receive coil specifically for rat brain imaging respectively
(RAPID Biomedical GmBH, Rimpar, Germany). The rat brain was positioned at the isocenter
of the magnet and located with a fast gradient echo scout scan. Shimming of first and second
order shims was performed on a whole-brain voxel using the FASTMAP technique [14] and
shim quality was confirmed using point resolved spectroscopy (PRESS) of the water peak.
T2-weighted images were acquired using a fast spin echo (FSE) sequence with TR/TE = 3000/
40ms, 28x28mm field of view (256 x 256 matrix), 22 x 1mm coronal slices and 2 signal averages
(scan duration = 6mins 28secs). DTI were acquired using a FSE sequence with TR/TE = 2380/
35 ms, 28x28 mm field of view (128 x 128 matrix), 22 x 1.0 mm coronal slices, 2 signal averages,
14 encoding directions, 10.37 G/cm gradient pulse of 5 ms duration and 26 ms separation,
maximum b-value = 1024 s/mm2 (scan duration = 13 mins). All images were corrected for
intensity inhomogeneities introduced by the 2-channel surface receive coil using the bias field
correction method in 3DSlicer, Version 3.6 (http://www.slicer.org [15]) Region-of-interest
(ROI) analysis of lesion volume was performed on T2-weighted images in ImageJ, Fiji (www.
imagej.net [16]).
Image slices including a lesion component were identified and three repeat measurements
of lesion area, ipsilateral hemisphere area and contralateral hemisphere area were manually
delineated on each slice by an experienced operator, blinded to experimental group allocation.
Area measurements were multiplied by slice thickness to calculate volume. Total lesion volume
was corrected for the effects of edema by dividing lesion volume by the ratio of ipsilateral to
contralateral hemisphere volume on a slice-by-slice basis.
ADC and FA maps were generated from DTI data using the diffusion analysis method in
VnmrJ, Version 4.2 (Agilent Technologies, Santa Clare, CA, USA). Lesion core ROIs were
identified on thresholded diffusion-weighted images. Linear registration of diffusion-weighted
and T2-weighted images was performed using the General Registration (BRAINS) module in
3DSlicer. Following registration, subtraction of diffusion-weighted lesion core ROIs from
T2-weighted total lesion ROIs resulted in an estimated penumbra ROI. These ROIs were
applied to ADC and FA maps to calculate mean ADC and FA within the core and penumbra
of the ipsilateral hemisphere, and were also translated about the midline to provide corre-
sponding contralateral ROIs.
Staircase test
The staircase task, developed by Montoya et al. [17] was used to assess forelimb function fol-
lowing MCAO. Animals were given a minimum of 90 minutes food deprivation prior to test-
ing and completed 3 days of training, with 2 trials per day, prior to the baseline test. The
baseline test was completed 7 days prior to MCAO. Post-MCAO tests were carried out on
post-surgical days 6, 13, 20 and 27. For the baseline test and all subsequent post-MCAO tests
one sucrose pellet (45 mg) was placed on the top step of the staircase and three pellets on the
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other six steps. Animals had fifteen minutes in which to retrieve as many pellets as possible.
The number of pellets retrieved by each paw was recorded. Animals that failed to retrieve any
pellets from the contralateral forelimb at baseline were excluded from analysis.
Adhesive test
The adhesive task was used to evaluate sensorimotor function of the forelimbs following MCAO.
Baseline performance was assessed 11 days prior to MCAO and post-MCAO tests were carried
out on days 3, 10, 17 and 24 post-MCAO. Round stickers were attached to the forepaws of each
animal. The animals were then placed into a clean, empty cage and the time taken to remove the
stickers was recorded. All tests were video-recorded to allow for timing confirmation. On each
test day animals completed the task 4 times, with a break between trials. The order in which the
stickers were placed on the paws were randomised, each animal received the sticker on the right
paw twice and the left paw twice. The time taken to remove the stickers were averaged over the 4
trials of each test and displayed as a percentage of the baseline time.
Cylinder test
The cylinder test was developed by Schallert et al. [18] and was used to determine forelimb
asymmetry. Rats were placed into a clear Perspex cylinder 20 cm in diameter and 50 cm in
length for 5 minutes. Animals were video recorded in each test and a mirror was positioned at
the rear of the cylinder so all paw placements would be captured on the video recording. The
video recordings were analysed and the number of rears and which forepaw was placed on the
wall of the cylinder first was recorded. The cylinder test was conducted on the same days as the
adhesive test, with the order of the two tests being randomised.
Statistical analysis
All statistical analysis was carried out using GraphPad Prism 7. All data are shown as
mean ± standard error of the mean (SEM). Two way analysis of variance (ANOVA) was used
to analyse behavioural data with time and intervention as the factors, followed by sidak cor-
rected post-hoc comparisons. A Kruskall-Wallis test was used to analyses non-parametric data
where two or more means were being compared (FA and ADC data) and CBF, lesion volume
and swelling data were analysed using unpaired, two tailed Students t-test. Mantel-Cox test
was used to analyse survival data. Significance was set at P< 0.05.
Results
Cerebral blood flow
All animals showed a decrease in CBF, relative to pre-ischemic CBF values, following MCAO.
There was no correlation between percentage decrease in CBF (38.95 ± 4.21%, n = 14) and
lesion volume when corrected for brain swelling (41.43 ± 6.64 mm3, n = 14; r = -0.037,
P = 0.90). Additionally there was no significant difference between the percentage decrease in
CBF following induction of ischemia between the control group (33.63 ± 5.63%, n = 7) and the
craniotomy group (M = 44.27 ± 5.98%, n = 7; t(12) = 1.30, P = 0.22).
Survival. Of the 18 animals, 13 survived until the 28-day post-MCAO end point. Survival
analysis showed no significant difference in survival rate between the two groups (P = 0.32).
One control animal died during MCAO and was excluded from all data analysis. Two animals
(1 control, 1 craniotomy) were humanely killed prior to the 48h post-MCAO MRI scan and
were excluded from all data analysis. One craniotomy animal was humanely killed following
the 48h post-MCAO MRI scan and was included in the lesion/edema data analysis but not
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included in the behavioural data analysis. Finally, 1 control animal died on post-MCAO day
26 and was excluded from the neurological score and staircase test analysis.
Effects of craniotomy on lesion volume and brain swelling
At 48 hours following MCAO there was no significant difference in the amount of ischemic
damage present, as indicated by total lesion volume obtained from T2-weighted MRI scans
(Fig 1), between the control group (41.15 ± 10.11 mm3, n = 7) and the craniotomy intervention
group (48.05 ± 10.33 mm3, n = 8) when corrected for brain swelling (t(13) = 0.475, P = 0.846).
In order to test for differences in brain swelling between the control and craniotomy
groups, the volume of the ipsilateral and contralateral hemispheres was measured, allowing the
volume of the ipsilateral hemisphere to be calculated as a percentage of the contralateral hemi-
sphere. There was no significant difference (t13 = 0.49, P = 0.63) in the volume percentage of
the ipsilateral hemisphere between the control group (102 ± 0.78%, n = 7) and the craniotomy
group (102 ± 0.84%, n = 8).
MRI diffusion tensor images were used to measure FA, a measure of local water diffusion
anisotropy, and ADC, a measure of the extent of water diffusion, for both core and penumbral
ROIs within both the ipsilateral, i.e. ischemic, and mirrored contralateral hemispheres. Within
the control and craniotomy groups there was no significant difference between the ipsilateral
and contralateral FA in the core (control, P = 0.26; craniotomy, P = 0.45) or penumbral (con-
trol, P = 0.82; craniotomy, P = 0.66) regions. There were also no significant differences in FA
between the control and craniotomy groups for the core (P =>0.99) and penumbra (P = 0.99)
regions of the ipsilateral hemisphere. In addition, ADC values did not differ significantly
between the ipsilateral and contralateral hemispheres in the core (control, P =>0.99; craniot-
omy, P =>0.99) or penumbral (control, P =>0.99; craniotomy, P =>0.99) regions within the
control and craniotomy groups. Additionally, ADC values of the core (P = >0.99) and
Fig 1. Effect of craniotomy on ischemic lesion volume as calculated from T2-weighted MRI images. (a) Representative
T2-weighted MRI coronal images from the control group (a) and craniotomy (b) group of the lesion in the rat brain. (c) Graph
showing lesion volume (mm3) and corrected against the size of the contralateral hemisphere to account for swelling. There was
no significant difference in lesion volume between groups (control n = 7, craniotomy n = 8).
https://doi.org/10.1371/journal.pone.0209370.g001
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penumbra (P =>0.99) of the ipsilateral hemisphere did not differ between the control and cra-
niotomy groups (Fig 2).
Indicators of wellbeing following MCAO
Each animal was weighed every day from the day of MCAO surgery up until 28 days post-
MCAO as an indicator of general wellbeing (Fig 3A). There was a significant main effect, as
analysed by a two-way ANOVA, of time on body weight for all animals (F28, 308 = 89.6, P =
<0.01) but there was no main effect of surgical intervention on body weight (F1,11 = 0.03,
P = 0.88) and no interaction between intervention and time (F28, 309 = 0.2, P =>0.99; control
n = 6, craniotomy n = 7).
A 28-point neurological score was used to measure the animals’ neurological outcome fol-
lowing MCAO. There was a significant main effect of time on neurological score (F5, 55 = 9.35,
P =<0.01) but no significant effect of intervention (F1, 11 = 0.1, P = 0.75) and no interaction
(F5, 55 = 1.68, P = 0.15) between the two groups (Fig 3B). On post-MCAO days 1 and 2 control
animals had a significantly worse neurological score compared to day 9 (vs. day 1, t55 = 3.29,
P = 0.03; vs. day 2, t55 = 3.67, P =<0.01), day 16 (vs. day 1, t55 = 3.93, P =<0.01; vs. day 2, t55 =
4.31, P =<0.01) or day 28 (vs. day 1, t55 = 3.8, P = <0.01; vs. day 2, t55 = 4.18, P =<0.01).
Additionally, the neuroscore on day 2 was significantly worse than day 23 post-MCAO (t55 =
3.42, P =<0.01). Thus, control animals showed a significant improvement in neurological
function from the first 48 hours following stroke, whilst there was no significant differences in
score across the test days of the craniotomy animals.
Functional assessment following MCAO
The staircase test was used to assess the effect of MCAO on grasping and motor ability of the
forelimbs. The number of pellets retrieved by the ipsilateral paw showed a significant main
Fig 2. Effect of craniotomy on oedema formation at 48 hours post-MCAO. (a) The volume of the lesioned
hemisphere as measured using T2-weighted MRI images, is displayed as a percentage of the unaffected hemisphere.
There are no significant differences between the control and craniotomy groups. Craniotomy had no significant effect
on the FA (b) and ADC (c) values of either the core or penumbra of the lesion as measured using DTI. Lines indicate
mean ± SEM, closed circles are individual data points (control, n = 7; craniotomy, n = 8).
https://doi.org/10.1371/journal.pone.0209370.g002
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effect of time (F4, 36 = 8.31, P =<0.01) but not intervention (F1, 9 = 1.10, P = 0.32) and there
was no interaction (F4, 36 = 1.50, P = 0.22; Fig 4A). Post hoc analysis showed that the control
group retrieved significantly more pellets on days 20 (9.2 ± 1.2, t36 = 3.39, P = 0.02) and 27
(9.2 ± 0.66, t36 = 3.39, P = 0.02) compared to day 6 (4.8 ± 1.28, n = 5). The craniotomy group
successfully grasped significantly more pellets on day 27 following MCAO (9 ± 2.52) than on
day 7 pre-MCAO (3.67 ± 1.09, t36 = 4.50, P =<0.01) and day 6 post-MCAO (4.33 ± 1.67, t36 =
3.94, P =<0.01). This shows that both groups improved their performance and retrieved more
Fig 3. Effect of craniotomy on body weight and neurological score post-MCAO. (a) Body weights were recorded
daily as a measure of wellbeing and both groups significantly increased weight over time (P =<0.0001). Arrow
represents the point of MCAO. (b) A 28-point neurological score was used to measure functional outcome,
craniotomy had no significant effect on neurological score, however there was a significant main effect of time (��P =
<0.001). Data is displayed as mean ± SEM; control n = 6, craniotomy n = 7.
https://doi.org/10.1371/journal.pone.0209370.g003
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pellets over time but neither group performed better than the other (Fig 4A). The number of
pellets retrieved by the contralateral (to the site of MCAO) paw was significantly affected by
time (F4, 36 = 5.95, P =<0.01) but not intervention (F1, 9 = 0.07, P = 0.80) and there was no
interaction (F4, 36 = 0.84, P = 0.84). Results of the post hoc analysis showed a significant
decrease within the control group between the number of pellets eaten on day 7 pre-MCAO
(8.2 ± 0.74) and 6 days post-MCAO (1.8 ± 1.36, t36 = 3.52, P = 0.01) and the number of pellets
retrieved was significantly increased on day 20 (8.6 ± 2.98) compared to day 6 (1.8 ± 1.36, t36 =
3.74, P =<0.01). No significant differences were found between the time points within the cra-
niotomy group in terms of the contralateral paw, unlike control animals who did have a signif-
icant impairment of the affected limb following MCAO, however this impairment was
recovered by day 20 (Fig 4B).
Sensorimotor ability following MCAO was assessed using the adhesive sticker test. A two-
way ANOVA showed that there was no significant main effect of time on the time taken to
remove the stickers from the ipsilateral paw (F4, 48 = 2.38, P = 0.06), no effect of intervention
(F1, 12 = 0.51, P = 0.49) and no interaction between time and intervention (F4, 48 = 0.54,
P = 0.7; Fig 4C). In terms of the time taken by the contralateral paw to remove the sticker (Fig
4D), there was a significant main effect of time (F4, 48 = 4.7, P =<0.01) but there was no effect
of intervention (F1, 12 = 0.72, P = 0.41) and no interaction (F4, 48 = 0.51, P = 0.73). Post hoc
tests revealed that there was a significant increase in time taken to remove the contralateral
sticker by the craniotomy group at day 3 post-MCAO (419.15 ± 176.86%) compared to 11 days
prior to MCAO (100 ± 0%, t48 = 1.926, P = 0.0074), showing a significant impairment of the
affected forelimb at this time point.
The cylinder test was used to assess forelimb asymmetry following MCAO. There was a sig-
nificant main effect of time (F4,48 = 6.22, P =<0.01) on the total number of paw placing rears
made during the cylinder test (Fig 4E), but no effect of intervention (F1,12 = 0.85, P = 0.38) or
any interaction (F4,48 = 0.19, P = 0.94). Within the craniotomy group, post hoc analysis revealed
that there were significantly less rears performed on days 3 (9 ± 1.81, t48 = 3.622, P =<0.01)
and 24 (10.57 ± 1.46, t48 = 3.12, P = 0.03) compared to baseline at 11 days pre-MCAO
(20.29 ± 1.7, n = 7). With regard to those rears performed by the contralateral paw, there was a
significant effect of time (F4,48 = 4.56, P =<0.01) but no effect of craniotomy intervention
(F1,12 = 0.0009, P = 0.98) and no interaction between the two (F4,48 = 0.63, P = 0.64). Post hoc
analysis of the craniotomy group’s performance showed that a significantly lower percentage
of paw placing rears were performed with the contralateral paw on days 3 (22.14 ± 10.89, t48 =
3.08, P = 0.03), 17 (22.14 ± 11.6, t48 = 3.08, P = 0.03) and 24 (20.8 ± 7.52, t48 = 3.22, P = 0.02)
compared to 11 days pre-MCAO (51.63 ± 4.7, n = 7; Fig 4F), suggesting a significant
impairment in their contralateral paw, whilst there were no significant differences across the
time points in the control groups contralateral limb usage.
Discussion
In accordance with previous findings [10] this study, in normotensive animals, failed to show
any effect of pre-stroke craniotomy on lesion volume and functional outcome up to 28 days
following 60 minutes of MCAO. However, despite craniotomy proving beneficial in terms of
reducing weight loss and increasing survival post-MCAO in spontaneously hypertensive rats
(SHRs) the same benefits were not seen here in Sprague-Dawley rats. A possible reason for this
may be that there is only a benefit of craniotomy when there are large lesions as SHRSPs have
been shown to suffer significantly larger lesions than normotensive control animals [19–21].
Also, in clinical trials that found reduced mortality following craniectomy in humans, partici-
pants were included if they had a National Institutes of Health Stroke Scale of more than 20,
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which correlates to a moderate to severe stroke [22]. Thus it is possible that this treatment is
only beneficial to both animals and humans who have large infarcts. However, as we only
investigated the effect following 60 minutes of MCAO we cannot rule the possibility that a lon-
ger duration of MCAO might have produced a different effect. In addition, it may be that the
size and location of the craniotomy also determines its impact on outcome measures following
ischemic stroke.
Transient MCAO by an intraluminal thread is a commonly used model of focal cerebral
ischemia in rats (and mice) and, as others have stated [23], it is typically induced for sixty,
ninety or one hundred and twenty minutes. As we only tested one duration of MCAO, i.e.
sixty minutes, we cannot exclude the possibility that a longer duration may have yielded differ-
ent results. Various factors affect the extent and severity of the ischemic infarct including
occlusion duration, the type of surgical method employed, animal strain and post-ischemia
recovery time [24]. Depending on the duration of the occlusion, the method used here typi-
cally results in an infarct area encompassing the striatum and the overlying frontoparietal and
temporal cortices, as well as a portion of the occipital cortex and some involvement of the thal-
amus and hypothalamus [25]. Here we chose sixty minutes of ischemia which produced a
quantifiable and reproducible infarct area as we were attempting to minimise the impact, from
an animal welfare perspective, whilst still demonstrating a quantifiable and reproducible
lesion.
Focal ischemia, via MCAO, in SHRs and stroke-prone SHRs tends to result in relatively
large infarcts [26, 27] whereas in Sprague-Dawley rats, as used here, MCAO tends to result in
smaller infarct volumes which are associated with considerable variability [17, 28]. Despite this
variability, Sprague-Dawley rats are the most commonly used species in preclinical stroke
studies [29] with approximately 60% of all neuroprotection data coming from the Sprague-
Dawley strain [30]. In terms of lesion volume produced the volumes we report here are compa-
rable to other studies which have reported lesions in the range of 150 mm3 in Wistar rats and
but as small as 30 mm3 in Sprague Dawley rats following ninety minutes of MCAO [28, 31].
However, it is difficult to compare lesion volumes between studies due to a number of vari-
ables including anesthetic regime, surgical experience, recovery conditions animals are
exposed to during recovery and the method and timing used to determine infarct area.
Given the variability seen within our data, although consistent with reports in the literature,
and the fact that we saw no differences in our primary outcome measure i.e. lesion volume, it
is of course relevant to consider whether our study failed to identify a significant difference
between groups due to being underpowered. Although we can use the group means and stan-
dard deviations for lesion volume to perform a retrospective power analysis, this tells us that
many more animals per group i.e. over 200, would be required to detect a difference in lesion
volume, assuming all other experimental parameters were comparable to those described here.
Of course, this may suggest the current study is either underpowered or that there is actually
no biologically relevant difference between the two groups (i.e. no type II error). The aim of
this study was to determine if a pre-stroke craniotomy procedure had any benefit to normo-
tensive animals undergoing stroke studies. The lack of a significant difference in lesion volume
between the control and craniotomy groups implies that for the majority of experimental
Fig 4. Effect of craniotomy on functional outcome as measured by the staircase test, adhesive test and cylinder test. The time taken to remove the sticker from
the ipsilateral and contralateral paw in the adhesive test is displayed as a percentage of the baseline performance, there is no significant difference between the
control and craniotomy groups performance (Control, n = 7; craniotomy, n = 7). The staircase test data is displayed as the number of pellets retrieved by the
ipsilateral and contralateral paw, there is no significant effect of craniotomy on performance. (Control, n = 5; craniotomy, n = 6). Total number of paw placing rears
performed in the cylinder test are displayed and also the percentage of paw placing rears in which the contralateral paw was placed first. (Control, n = 7; craniotomy,
n = 7). Arrows represent the point of MCAO. Data is presented at mean ± SEM; � =<0.05, �� =<0.01, ��� =<0.005.
https://doi.org/10.1371/journal.pone.0209370.g004
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stroke studies, which typically use 8–16 animals per group, and apply similar parameters as
described here (type and duration of vessel occlusion), pre-stroke craniotomy will have a negli-
gible effect on lesion volume.
In order to allow animals to progress through the functional tests we used non-invasive
MRI scanning for quantification of lesion volume. MRI has been shown, in animal stroke
models, to detect the evolving ischemic damage and allows a multi-parametric analysis of tis-
sue status [13, 32]. T2 weighted images allow tissue damage to be characterized which reflects
final infarct volume, correlates with clinical deficit and identifies tissue damage early following
stroke. T2 weighted images provide an estimate of the vasogenic edema and blood-brain bar-
rier disruption indicative of irreversible damage [33–35]. In addition, we used diffusion-
weighted MRI to separate the ischemic lesion into core and penumbra regions and also to
quantify regional ADC and FA. The lack of significant difference in core and penumbral vol-
ume and for ADC and FA measurements between the control and craniotomy groups further
supports the T2-weighted lesion volume data.
Despite the welfare benefits of a pre-MCAO craniotomy procedure in SHRs being identi-
fied Ord et al [10] failed to determine the mechanistic actions of the craniotomy that led to
reduced mortality and weight loss. Possible mechanisms may include protection from pre-
MCAO exposure to isoflurane, although this is unlikely when pre-conditioning happened 6
days prior to MCAO as the protective effect of isoflurane has only been observed when given
up to 24 hours prior to MCAO [36]. Furthermore, isoflurane pre-conditioning has been
shown to improve neurological reduce infarct volume [37], effects that were not observed in
our study or the previous one [10]. It may be that the pre-MCAO intervention reduced the
effect of oedema by allowing excess fluid to escape through the gap produced in the dura,
therefore preventing a rise in intracranial pressure and improving outcome. However this is
not the case in normotensive animals as we failed to show any difference between the craniot-
omy group and the control group in the amount of swelling in the lesioned hemisphere.
Drug development remains key in the search for effective pharmacological treatments for cere-
bral ischemic stroke. However, the blood brain barrier (BBB), although critical for maintaining
physiological homeostasis within the brain, can hinder the delivery of therapeutic agents to the
brain [38, 39]. Although the BBB is disrupted following ischemic stroke this tends to be only par-
tially and at a delayed time point, typically at least 12 hours in human patients, following ischemic
stroke [40, 41]. There are many experimental studies which, in the early stages of investigating a
potential drug treatment for ischemic stroke, do utilise intracranial delivery of a candidate drug,
via craniotomy. Thus, although we did not identify any effect of pre-MCAO craniotomy, on wel-
fare measures, the lack of any effect on lesion volume and behavioural function indicates that the
craniotomy method for drug delivery should be expected to have minimal impact on those out-
come measures typically used in experimental stroke studies.
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